Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Endologix Inc.

Latest From Endologix Inc.

MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change

The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings. 

International Commercial

Leak Risk Tied To Endologix Grafts Found In More Models, FDA Says

A recent warning from the US agency ties two additional models of AFX endovascular grafts from Endologix Inc. to potentially fatal blood leaks. An earlier model of the devices, which are used to treat abdominal aortic aneurysms, was removed from the market last year over similar concerns.

Regulation Cardiology

Pacts In Medtech: Audax Buys Hill-Rom’s Surgical Consumables; Boston Scientific To Distribute Endologix’s Products In China

Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, research and development partnerships and commercial collaborations. This edition covers industry pacts that were signed in July and August 2019.

Pacts in Medtech Deals

Discontinued Endologix AAA Graft Device Singled Out In Updated FDA Alert

US FDA says that previously identified elevated risks of type III endoleaks from endovascular aneurysm repair systems appears to be linked to a specific, no-longer-sold device, Endogix's AFX with Strata system.

Safety Regulation
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Radiance Medical
  • Cardiovascular Dynamics Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Endologix Inc.
  • Senior Management
  • John Onopchenko, CEO
    Vaseem Mahboob, CFO
    Matthew Thompson, MD, CMO
    W. Patrick Stephens, VP, R&D
    Jeffrey S Brown, COO
    John D Zehren, Chief Commercial Officer
  • Contact Info
  • Endologix Inc.
    Phone: (949) 595-7200
    2 Musick
    Irvine, CA 92618